What is the ticker symbol for Tempest Therapeutics?

Tempest Therapeutics trades under the ticker TPST on NASDAQ.

What sector does Tempest Therapeutics operate in?

Tempest Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze TPST in a portfolio?

PortView shows TPST's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Tempest Therapeutics (TPST) Stock Analysis

NASDAQHealthcareBiotechnology

$1.09+3.81%

1-year price historyRange $0.86 – $11.83

52-week range$1.09

$0.84$12.23

What Tempest Therapeutics does

Tempest Therapeutics Inc. is an oncology company, currently in the clinical development phase, dedicated to advancing novel small molecule drugs designed to combat cancer. The firm's pipeline highlights two key therapeutic candidates: TPST-1495, a compound functioning as a dual inhibitor of EP2 and EP4 receptors (which are implicated in prostaglandin E2 signaling), currently undergoing initial human trials for solid tumor indications. The second candidate, TPST-1120, is a targeted blocker of peroxisome proliferator-activated receptor alpha, also progressing through Phase 1 studies for solid tumors. Beyond these clinical assets, Tempest is exploring TREX-1, a pivotal cellular enzyme known for its role in regulating the innate immune response within cancerous growths. Established in 2011, Tempest Therapeutics Inc. is headquartered in South San Francisco, California, having previously operated as a subsidiary of Inception Sciences, Inc.

Key metrics

Market cap

$17.42M

P/E (TTM)

-0.18

EPS (TTM)

$-6.01

Beta

-1.68

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$1.02

200-day avg

$2.12

52-week high

$12.23

52-week low

$0.84

CEO

Matthew Angel

ETFs linked to TPST

Broad-market and Healthcare sector ETFs an investor holding Tempest Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how TPST fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze TPST in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Tempest Therapeutics?: Tempest Therapeutics trades under the ticker TPST on NASDAQ.
Which exchange is TPST listed on?: TPST is listed on NASDAQ.
What sector does Tempest Therapeutics operate in?: Tempest Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze TPST in a portfolio?: PortView shows TPST's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.